Literature DB >> 11884210

Calcitonin gene related peptide in familial dysautonomia.

C Maayan1, Y Becker, B Gesundheit, S I Girgis.   

Abstract

Familial dysautonomia (FD) patients have diminished sensory C-fibers. Calcitonin gene related peptide (CGRP) is a widely distributed neuropeptide and prominent neurotransmitter in C-fibers. We show that plasma CGRP levels measured by radioimmunoassay is significantly lower in 51 FD patients compared to controls (P<0.001). In 11/51 FD patients with FD crisis and in 19/51 FD patients with pneumonia, the mean CGRP levels rose significantly as compared to their baseline (P<0.003, P<0.001, respectively). The deficiency of CGRP in FD patients is consistent with their depletion of C-fibers, and may explain some of their symptoms, either directly or via modulation of sympathetic activity. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11884210     DOI: 10.1054/npep.2001.0863

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  8 in total

1.  Lack of migraine in headaches of familial dysautonomia patients.

Authors:  Boris Shihman; Israel Steiner; Ivelin Yovchev; Channa Maayan
Journal:  J Neural Transm (Vienna)       Date:  2012-10-09       Impact factor: 3.575

Review 2.  Impact of the Autonomic Nervous System on the Skeleton.

Authors:  Florent Elefteriou
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

3.  Calcitonin-gene-related peptide stimulates stromal cell osteogenic differentiation and inhibits RANKL induced NF-kappaB activation, osteoclastogenesis and bone resorption.

Authors:  Liping Wang; Xiaoyou Shi; Rong Zhao; Bernard P Halloran; David J Clark; Christopher R Jacobs; Wade S Kingery
Journal:  Bone       Date:  2009-12-02       Impact factor: 4.398

4.  Substance P stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro.

Authors:  Liping Wang; Rong Zhao; Xiaoyou Shi; Tzuping Wei; Bernard P Halloran; David J Clark; Christopher R Jacobs; Wade S Kingery
Journal:  Bone       Date:  2009-04-18       Impact factor: 4.398

Review 5.  No pain, no gain? The effects of pain-promoting neuropeptides and neurotrophins on fracture healing.

Authors:  Seungyup Sun; Nicklaus H Diggins; Zachary J Gunderson; Jill C Fehrenbacher; Fletcher A White; Melissa A Kacena
Journal:  Bone       Date:  2019-11-09       Impact factor: 4.398

6.  Mice lacking substance P have normal bone modeling but diminished bone formation, increased resorption, and accelerated osteopenia with aging.

Authors:  Liping Wang; Saiyun Hou; Ilya Sabsovich; Tian-Zhi Guo; Tzuping Wei; Wade S Kingery
Journal:  Bone       Date:  2020-12-15       Impact factor: 4.398

7.  Neuropeptide Y, substance P, and human bone morphogenetic protein 2 stimulate human osteoblast osteogenic activity by enhancing gap junction intercellular communication.

Authors:  W H Ma; Y J Liu; W Wang; Y Z Zhang
Journal:  Braz J Med Biol Res       Date:  2015-02-13       Impact factor: 2.590

8.  Bone biomechanical properties and tissue-scale bone quality in a genetic mouse model of familial dysautonomia.

Authors:  G Vahidi; H Flook; V Sherk; M Mergy; F Lefcort; C M Heveran
Journal:  Osteoporos Int       Date:  2021-05-25       Impact factor: 4.507

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.